Insider sale
DYNE THERAPEUTICS, INC.
$2.47M
94.42K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND II, L.P. plans to sell 94.42K shares of DYNE THERAPEUTICS, INC. valued at approximately $2.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001628280-26-056844
10% Owner
Since Dec 2022
94.42K
Shares to sell
$2.47M
Approx. market value
94.42K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
12/12/2022
94.42KTotal acquired94.42K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2022 | Private Placement Cash | 94.42K | — |
| Total | 94.42K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
94.42K
Market value
$2.47M
8/13/2026
Total
Units
94.42K
Value
$2.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/13/2026 | 94.42K | $2.47M | Nasdaq | Planned |
| Total | 94.42K | $2.47M | ||